Avacta’s Affimer molecules can be used as therapeutics
Avacta Group will present detailed data from the first pre-clinical in-vivo studies of its therapeutic Affimer platform
Pharmaceuticals, Biotechnology and Life Sciences
Avacta Group will present detailed data from the first pre-clinical in-vivo studies of its therapeutic Affimer platform
Advanced Oncotherapy has announced that Lord David Evans has stepped down
French Genfit has raised €78.5 million and invests in its R&D
Mylan NV’s price hikes on EpiPens have added millions to U.S. Department of Defense spending…
BD has gotten FDA market authorization for a first-of-its-kind molecular test…
HeartWare is recalling the HVAD controller due to a loose power connector which may cause …
Premaitha Health has gotten UK’s Department of Health approval to make non-invasive prenatal tests (“NIPT”)
Sanofi and Regeneron Pharmaceuticals have announced the FDA issued a Complete Response Letter (CRL) regarding…
Allergan has received approval from the FDA for Restasis, treatment to help patients with a type of Chronic Dry Eye …
Finish patent office has accepts Faron’s new formulation for a respiratory orphan disease ARDS